vs
西门子能源（REI）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是西门子能源的1.0倍（$69.8M vs $66.9M），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -19.8%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -15.9%）
西门子能源是一家上市能源企业，从原西门子天然气与电力部门分拆而来，目前为独立经营的德国企业，旗下全资拥有西门子歌美飒，业务覆盖全球能源领域的技术开发与项目运营，为各类客户提供专业的能源解决方案。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
REI vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.0倍
$66.9M
营收增速更快
RIGL
高出41.0%
-19.8%
两年增速更快
RIGL
近两年复合增速
-15.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $66.9M | $69.8M |
| 净利润 | — | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | -37.6% | 33.2% |
| 净利率 | — | 384.0% |
| 营收同比 | -19.8% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $-0.07 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收REIRIGL
| Q4 25 | $66.9M | $69.8M | ||
| Q3 25 | $78.6M | $69.5M | ||
| Q2 25 | $82.6M | $101.7M | ||
| Q1 25 | $79.1M | $53.3M | ||
| Q4 24 | $83.4M | $57.6M | ||
| Q3 24 | $89.2M | $55.3M | ||
| Q2 24 | $99.1M | $36.8M | ||
| Q1 24 | $94.5M | $29.5M |
净利润REIRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $-51.6M | $27.9M | ||
| Q2 25 | $20.6M | $59.6M | ||
| Q1 25 | $9.1M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $33.9M | $12.4M | ||
| Q2 24 | $22.4M | $-1.0M | ||
| Q1 24 | $5.5M | $-8.2M |
毛利率REIRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率REIRIGL
| Q4 25 | -37.6% | 33.2% | ||
| Q3 25 | -70.0% | 40.9% | ||
| Q2 25 | 28.4% | 60.1% | ||
| Q1 25 | 28.3% | 23.9% | ||
| Q4 24 | 28.3% | 28.9% | ||
| Q3 24 | 33.4% | 25.4% | ||
| Q2 24 | 42.2% | 1.2% | ||
| Q1 24 | 39.8% | -23.6% |
净利率REIRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | -65.7% | 40.2% | ||
| Q2 25 | 25.0% | 58.6% | ||
| Q1 25 | 11.5% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | 38.0% | 22.5% | ||
| Q2 24 | 22.6% | -2.8% | ||
| Q1 24 | 5.8% | -27.9% |
每股收益（稀释后）REIRIGL
| Q4 25 | $-0.07 | $14.11 | ||
| Q3 25 | $-0.25 | $1.46 | ||
| Q2 25 | $0.10 | $3.28 | ||
| Q1 25 | $0.05 | $0.63 | ||
| Q4 24 | $0.03 | $0.82 | ||
| Q3 24 | $0.17 | $0.70 | ||
| Q2 24 | $0.11 | $-0.06 | ||
| Q1 24 | $0.03 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $902.9K | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $836.3M | $391.5M |
| 总资产 | $1.4B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资REIRIGL
| Q4 25 | $902.9K | $155.0M | ||
| Q3 25 | $286.9K | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | $1.1M | $77.1M | ||
| Q4 24 | $1.9M | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | $1.2M | $49.1M | ||
| Q1 24 | $1.4M | $49.5M |
总债务REIRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益REIRIGL
| Q4 25 | $836.3M | $391.5M | ||
| Q3 25 | $847.7M | $117.6M | ||
| Q2 25 | $897.9M | $81.9M | ||
| Q1 25 | $876.0M | $18.6M | ||
| Q4 24 | $858.6M | $3.3M | ||
| Q3 24 | $851.3M | $-14.6M | ||
| Q2 24 | $817.4M | $-29.9M | ||
| Q1 24 | $793.0M | $-31.7M |
总资产REIRIGL
| Q4 25 | $1.4B | $513.6M | ||
| Q3 25 | $1.4B | $242.5M | ||
| Q2 25 | $1.5B | $206.7M | ||
| Q1 25 | $1.5B | $176.0M | ||
| Q4 24 | $1.4B | $164.0M | ||
| Q3 24 | $1.4B | $139.4M | ||
| Q2 24 | $1.4B | $128.4M | ||
| Q1 24 | $1.4B | $126.5M |
负债/权益比REIRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $44.7M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流REIRIGL
| Q4 25 | $44.7M | $22.0M | ||
| Q3 25 | $44.5M | $24.0M | ||
| Q2 25 | $33.3M | $30.5M | ||
| Q1 25 | $28.4M | $-893.0K | ||
| Q4 24 | $47.3M | $14.5M | ||
| Q3 24 | $51.3M | $21.7M | ||
| Q2 24 | $50.6M | $302.0K | ||
| Q1 24 | $45.2M | $-5.0M |
现金转化率REIRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | 1.61× | 0.51× | ||
| Q1 25 | 3.11× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 1.52× | 1.75× | ||
| Q2 24 | 2.26× | — | ||
| Q1 24 | 8.19× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
